Literature DB >> 10945035

T lymphocyte and fibroblast interactions: the case of skin involvement in systemic sclerosis and other examples.

C Chizzolini1.   

Abstract

Entities:  

Mesh：

Year:  1999        PMID： 10945035     DOI： 10.1007/s002810000035

Source DB:  PubMed          Journal:  Springer Semin Immunopathol        ISSN： 0344-4325


× No keyword cloud information.
  157 in total

Review 1.  The chemokine system: redundancy for robust outputs.

Authors:  A Mantovani
Journal:  Immunol Today       Date:  1999-06

2.  Leukoregulin down-regulates type I collagen mRNA levels and promoter activity in human dermal fibroblasts, and counteracts the up-regulation elicited by transforming growth factor-beta.

Authors:  A Mauviel; C H Evans; J Uitto
Journal:  Biochem J       Date:  1992-06-15       Impact factor: 3.857

3.  Dermal mast cells in scleroderma: their skin density, tryptase/chymase phenotypes and degranulation.

Authors:  S Akimoto; O Ishikawa; Y Igarashi; M Kurosawa; Y Miyachi
Journal:  Br J Dermatol       Date:  1998-03       Impact factor: 9.302

4.  Selective up-regulation of chemokine receptors CCR4 and CCR8 upon activation of polarized human type 2 Th cells.

Authors:  D D'Ambrosio; A Iellem; R Bonecchi; D Mazzeo; S Sozzani; A Mantovani; F Sinigaglia
Journal:  J Immunol       Date:  1998-11-15       Impact factor: 5.422

5.  Interleukin-10 modulates type I collagen and matrix metalloprotease gene expression in cultured human skin fibroblasts.

Authors:  S Reitamo; A Remitz; K Tamai; J Uitto
Journal:  J Clin Invest       Date:  1994-12       Impact factor: 14.808

6.  Lymphocyte modulation of fibroblast function in vitro: stimulation and inhibition of collagen production by different effector molecules.

Authors:  A E Postlethwaite; G N Smith; C L Mainardi; J M Seyer; A H Kang
Journal:  J Immunol       Date:  1984-05       Impact factor: 5.422

7.  Differential monocyte chemoattractant protein-1 and chemokine receptor 2 expression by murine lung fibroblasts derived from Th1- and Th2-type pulmonary granuloma models.

Authors:  C M Hogaboam; C L Bone-Larson; S Lipinski; N W Lukacs; S W Chensue; R M Strieter; S L Kunkel
Journal:  J Immunol       Date:  1999-08-15       Impact factor: 5.422

8.  Cytokine concentrations in bronchoalveolar lavage fluid of patients with systemic sclerosis.

Authors:  M B Bolster; A Ludwicka; S E Sutherland; C Strange; R M Silver
Journal:  Arthritis Rheum       Date:  1997-04

9.  Serial circulating adhesion molecule levels reflect disease severity in systemic sclerosis.

Authors:  C P Denton; M C Bickerstaff; X Shiwen; M T Carulli; D O Haskard; R M Dubois; C M Black
Journal:  Br J Rheumatol       Date:  1995-11

10.  Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s.

Authors:  R Bonecchi; G Bianchi; P P Bordignon; D D'Ambrosio; R Lang; A Borsatti; S Sozzani; P Allavena; P A Gray; A Mantovani; F Sinigaglia
Journal:  J Exp Med       Date:  1998-01-05       Impact factor: 14.307
View more
  6 in total

Review 1.  Adult xanthogranulomatous disease of the orbit and ocular adnexa: new immunohistochemical findings and clinical review.

Authors:  J A Sivak-Callcott; J Rootman; S L Rasmussen; R A Nugent; V A White; D Paridaens; Z Currie; G Rose; B Clark; A A McNab; F V Buffam; J M Neigel; M Kazim
Journal:  Br J Ophthalmol       Date:  2006-05       Impact factor: 4.638

Review 2.  Vasculopathy in scleroderma.

Authors:  Yoshihide Asano; Shinichi Sato
Journal:  Semin Immunopathol       Date:  2015-07-08       Impact factor: 9.623

3.  Serum IL-33 levels are raised in patients with systemic sclerosis: association with extent of skin sclerosis and severity of pulmonary fibrosis.

Authors:  Koichi Yanaba; Ayumi Yoshizaki; Yoshihide Asano; Takafumi Kadono; Shinichi Sato
Journal:  Clin Rheumatol       Date:  2011-01-19       Impact factor: 2.980

4.  Polarized subsets of human T-helper cells induce distinct patterns of chemokine production by normal and systemic sclerosis dermal fibroblasts.

Authors:  Carlo Chizzolini; Yann Parel; Agneta Scheja; Jean-Michel Dayer
Journal:  Arthritis Res Ther       Date:  2006       Impact factor: 5.156

5.  IL-13 and IL-33 Serum Levels Are Increased in Systemic Sclerosis Patients With Interstitial Lung Disease.

Authors:  Antonio Giovanni Versace; Alessandra Bitto; Carmelo Ioppolo; Caterina Oriana Aragona; Daniela La Rosa; William Neal Roberts; Tommaso D'Angelo; Antonella Cinquegrani; Santa Cirmi; Natasha Irrera; Michele Navarra; Salvatore Corrao; Sebastiano Gangemi; Gianluca Bagnato
Journal:  Front Med (Lausanne)       Date:  2022-02-17

Review 6.  Vascular Leaking, a Pivotal and Early Pathogenetic Event in Systemic Sclerosis: Should the Door Be Closed?

Authors:  Cosimo Bruni; Tracy Frech; Mirko Manetti; Francesca Wanda Rossi; Daniel E Furst; Amato De Paulis; Felice Rivellese; Serena Guiducci; Marco Matucci-Cerinic; Silvia Bellando-Randone
Journal:  Front Immunol       Date:  2018-09-07       Impact factor: 7.561
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.